These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31662747)
1. miR-29a Negatively Affects Glucose-Stimulated Insulin Secretion and MIN6 Cell Proliferation via Cdc42/ Duan J; Qian XL; Li J; Xiao XH; Lu XT; Lv LC; Huang QY; Ding W; Zhang HY; Xiong LX Int J Endocrinol; 2019; 2019():5219782. PubMed ID: 31662747 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer. Li Y; Wang Z; Li Y; Jing R Oncol Lett; 2017 May; 13(5):3896-3904. PubMed ID: 28521487 [TBL] [Abstract][Full Text] [Related]
3. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer. Chen R; Zhang L Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771 [TBL] [Abstract][Full Text] [Related]
4. Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling. Xiao XH; Huang QY; Qian XL; Duan J; Jiao XQ; Wu LY; Huang QY; Li J; Lai XN; Shi YB; Xiong LX Diabetes Metab Syndr Obes; 2019; 12():2325-2339. PubMed ID: 32009808 [TBL] [Abstract][Full Text] [Related]
5. Syntaxin-1a is a direct target of miR-29a in insulin-producing β-cells. Bagge A; Dahmcke CM; Dalgaard LT Horm Metab Res; 2013 Jun; 45(6):463-6. PubMed ID: 23315993 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion. Bagge A; Clausen TR; Larsen S; Ladefoged M; Rosenstierne MW; Larsen L; Vang O; Nielsen JH; Dalgaard LT Biochem Biophys Res Commun; 2012 Sep; 426(2):266-72. PubMed ID: 22940552 [TBL] [Abstract][Full Text] [Related]
7. miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1. Geng A; Luo L; Ren F; Zhang L; Zhou H; Gao X BMC Cancer; 2021 Jul; 21(1):843. PubMed ID: 34289832 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a Inhibits Growth, Migration and Invasion of Melanoma A375 Cells in Vitro by Directly Targeting BMI1. Xiong Y; Liu L; Qiu Y; Liu L Cell Physiol Biochem; 2018; 50(1):385-397. PubMed ID: 30286469 [TBL] [Abstract][Full Text] [Related]
9. Notoginsenoside R1 alleviates TNF-α-induced pancreatic β-cell Min6 apoptosis and dysfunction through up-regulation of miR-29a. Chen X; Wei R; Jin T; Du H Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2379-2388. PubMed ID: 31184222 [TBL] [Abstract][Full Text] [Related]
10. Identification of miR-9 as a negative factor of insulin secretion from beta cells. Hu D; Wang Y; Zhang H; Kong D J Physiol Biochem; 2018 May; 74(2):291-299. PubMed ID: 29470815 [TBL] [Abstract][Full Text] [Related]
11. miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway. Zhang F; Cao K; Du G; Zhang Q; Yin Z Adv Clin Exp Med; 2019 Oct; 28(10):1293-1300. PubMed ID: 31538414 [TBL] [Abstract][Full Text] [Related]
13. MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-κB Signaling Pathway. Gao XZ; Zhang ZX; Han GL J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105210. PubMed ID: 33066952 [TBL] [Abstract][Full Text] [Related]
14. miR-124 is upregulated in diabetic mice and inhibits proliferation and promotes apoptosis of high-glucose-induced β-cells by targeting EZH2. Duan XK; Sun YX; Wang HY; Xu YY; Fan SZ; Tian JY; Yu Y; Zhao YY; Jiang YL World J Diabetes; 2023 Mar; 14(3):209-221. PubMed ID: 37035229 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a-3p Downregulation Causes Gab1 Upregulation to Promote Glioma Cell Proliferation. Shao NY; Wang DX; Wang Y; Li Y; Zhang ZQ; Jiang Q; Luo W; Cao C Cell Physiol Biochem; 2018; 48(2):450-460. PubMed ID: 30016785 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-18 promotes apoptosis of islet β-cells via targeting NAV1. Fei H; Shi M; Chen L; Wang Z; Suo L Exp Ther Med; 2019 Jul; 18(1):389-396. PubMed ID: 31258677 [TBL] [Abstract][Full Text] [Related]
17. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer. Zhang M; Guo W; Qian J; Wang B Open Med (Wars); 2016; 11(1):78-82. PubMed ID: 28352771 [TBL] [Abstract][Full Text] [Related]
18. miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients. Shi C; Ren L; Sun C; Yu L; Bian X; Zhou X; Wen Y; Hua D; Zhao S; Luo W; Wang R; Rao C; Wang Q; Yu S Br J Cancer; 2017 Sep; 117(7):1036-1047. PubMed ID: 28787434 [TBL] [Abstract][Full Text] [Related]
19. Uncoupling protein 2 regulates daily rhythms of insulin secretion capacity in MIN6 cells and isolated islets from male mice. Seshadri N; Jonasson ME; Hunt KL; Xiang B; Cooper S; Wheeler MB; Dolinsky VW; Doucette CA Mol Metab; 2017 Jul; 6(7):760-769. PubMed ID: 28702331 [TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of novel candidate genes responsible for glucose-stimulated insulin secretion in mouse pancreatic β cell line MIN6. Yamato E; Tashiro F; Miyazaki J PLoS One; 2013; 8(4):e61211. PubMed ID: 23560115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]